Comprehensive commissioning of a cone beam CT imaging ring for treatment of HDR GYN patients

2024-9-1

Development and promotion of a 3D-printed phantom model for ultrasound-guided caudal block followed by intracavitary/interstitial brachytherapy for gynecological cancer

2024-9-1

Prostate size, source configuration, and dosimetry dynamics of stranded 125I seed implants

2024-9-1

Evaluation and improvement of the safety of 3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA

2024-9-1

Dosimetric evaluation of a novel modular cell irradiation platform for multi-modality in vitro studies including high dose rate brachytherapy

2024-9-1

Gynecological brachytherapy hybrid training: The Tata Memorial Centre and BrachyAcademy experience

2024-9-1

3D-printed individual template brachytherapy for the treatment of intractable central pelvic recurrent cervical cancer: A single institution experience

2024-9-1

Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer

2024-9-1

Masthead

2024-8-24

Editorial Board

2024-8-24

Table of Contents

2024-8-24

Mortality and postinterventional complications after ablative treatment of liver malignancies: A cohort study of 4374 patients

2024-8-1

Dosimetric evaluation of adaptive planning for five-fraction gynecologic template-based interstitial brachytherapy

2024-8-1

A novel 3D-printed brachytherapy applicator and monte Carlo model for the treatment of conjunctival tumors

2024-8-1

Comparison of 3D-printed multichannel non–co-planar vaginal applicators and single-channel vaginal applicators for brachytherapy with positive or close surgical margins in cervical cancer

2024-8-1

Determination of the optimal time for planning SAVI brachytherapy for APBI

2024-8-1

Are outcomes of locally advanced cervical cancer associated with prebrachytherapy hemoglobin values and transfusion practice? An observational study comparing two large academic centres with divergent clinical guidelines

2024-8-1

National Cancer Database analysis of radiation therapy consolidation modality and dose for inoperable endometrial cancer

2024-8-1

Commissioning considerations for the Bravos high-dose-rate afterloader: Towards improving treatment delivery accuracy

2024-8-1

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities

2024-8-1

Masthead

2024-7-1

Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence

2024-7-1

CT-guided iodine-125 brachytherapy is an effective palliative treatment for the right lower paratracheal lymph nodes metastasis previously treatment failure

2024-7-1

169Yb-based high dose rate intensity modulated brachytherapy for focal treatment of prostate cancer

2024-7-1

Editorial Board

2024-7-1

Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities

2024-7-1

Table of Contents

2024-7-1

Three-dimensional treatment-planning-based prediction of seed migration to chest after 125I seed brachytherapy for hepatic malignancy

2024-7-1

Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device

2024-7-1

Exclusive Ru-106 brachytherapy for the management of a recurrent corneo: Conjunctival squamous cell carcinoma

2024-7-1

A simple calibration routine for small inorganic scintillation detectors for in vivo dosimetry during brachytherapy

2024-6-8

My achy brachy heart: Resuscitating medical physics brachytherapy resident training

2024-6-8

Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience

2024-6-8

Inter-observer effects in needle reconstruction for temporary prostate brachytherapy: Dosimetric implications and adaptive CBCT-TRUS registration solutions

2024-6-6

Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients

2024-6-1

I-125 eye-plaque seed economics: To re-use or to not re-use? A single institutional cost savings analysis of re-using I-125 radioactive seeds for eye—Plaque brachytherapy

2024-5-28

To who and by who: Discussions of sexual health, fertility, and premature menopause with women with locally advanced cervical cancer

2024-5-10

Dosimetry of indigenously developed 106Ru-106Rh ophthalmic plaque

2024-5-9

Seed distribution stability in permanent breast seed implant brachytherapy

2024-5-9

Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up

2024-5-1

Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era

2024-5-1

Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study

2024-5-1

Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

2024-5-1

Impact on the estimated dose of different tissue assignment strategies during partial breast irradiations with INTRABEAM

2024-5-1

Editorial Board

2024-5-1

Table of Contents

2024-5-1

Masthead

2024-5-1

Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis

2024-5-1

Can an in-person hands-on applicator-based teaching session improve trainee knowledge and comfort with complex gynecologic brachytherapy?

2024-5-1

Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy

2024-4-19